| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8231922 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 7 Pages |
Abstract
Bcl-2 expression was a significant, independent determinant of biochemical control after neoadjuvant androgen deprivation and radical radiotherapy for prostate cancer. These data generate the hypothesis that Bcl-2 expression could be used to inform the choice of radiotherapy dose in individual patients.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Roy M.D., Catherine M. M.D., Karen B.Sc., Alan M.D., Ph.D., Robert M.D., Ph.D., Vincent M.D., Ros M.D., Ph.D., Matthew R. B.Sc., Colin S. Ph.D., David M.D., Chris M.D.,